安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Lucence | Advancing Precision Cancer Care
Fight cancer with a single draw of blood Lucence makes ultrasensitive and non-invasive Liquid Biopsy Tests for cancer detection and treatment
- LiquidHALLMARK® Liquid Biopsy: Personalized Cancer Care - Lucence
Lucence works with biopharmaceutical companies globally across all stages of the development pipeline from target discovery to companion diagnostics We are able to customize LiquidHALLMARK to meet your needs
- | Lucence
Lucence exists to push the limits of molecular diagnostics with purpose and precision – bringing clarity to cancer care Saving lives is our life’s work With sensitive and non-invasive liquid biopsy tests, we provide doctors and their “cancer-fighters” life-changing information so that they can seek effective treatments
- Lucence Launches LucenceINSIGHT to Detect Cancer Earlier
Lucence is launching LucenceINSIGHT™, an MCED test first internationally and with a follow-up U S launch in Q3 2023 This ctDNA-based liquid biopsy test screens for 10 common cancers in one blood draw Globally, 78% of cancer deaths occur in cancers without recommended routine screening [1]
- Resources and Clinical Studies - Lucence
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025
- News Events - Lucence
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics
- Agilus Diagnostics and Lucence Announce Strategic Collaboration to . . .
Lucence’s proprietary technology will empower Agilus Diagnostics to expand its oncology capabilities, offering liquid biopsy-based screening for early cancer detection, recurrence monitoring, and therapy personalization
- Mayo Clinic Laboratories and Lucence announce strategic collaboration . . .
Lucence, with its CLIA-licensed and CAP-accredited laboratories in California and Singapore, will provide access to its innovative LiquidHALLMARK® technology through Mayo Clinic Laboratories
|
|
|